Regulatory
Produce, Dairy Associations Urge Trump to Seek Other Trade Opportunities Following Trans-Pacific Partnership Exit
Also yesterday, more 130 U.S. food and agriculture industry representatives sent a letter to President Trump specifically asking the President to protect the opportunities of NAFTA.
From Trump to the FTC: 2017 Dietary Supplement Regulatory Issues to Watch
From the Trump administration to state attorneys general and the FDA/FTC, here are the key regulatory issues industry leaders are watching in 2017
2017 Ingredient Trends to Watch for Food, Drinks, and Dietary Supplements: Plant Protein vs. Dairy Protein
Tensions between dairy proteins and plant proteins are heating up, but which category stands to gain the most in 2017?
NPA Shares Its Industry Priorities with President-Elect Trump
In a letter sent to President-Elect Trump this week, NPA details top priorities for the supplement industry, including maternal and child nutrition, regulating NDIs, enforcing against kratom products, and more.
Dietary Supplement Contract Manufacturing in a Time of Trump
As Donald Trump is sworn in as President of the United States next week, Nutritional Outlook asks industry experts how his presidency could change the face of dietary-supplement contract manufacturing.
FTC Sues Prevagen Marketers for Making Unsubstantiated Claims
The supplement product’s extensive marketing campaign for memory benefits is based on “false and unsubstantiated claims,” according to the FTC.
CRN, IPA Announce Probiotic Best-Practice Guidelines
The new guidelines propose a multitude of best practices for the labeling, storing, and stability testing of dietary supplements and functional foods that include probiotics.
“New Congress Means New Opportunities,” NPA Says
“It is critical for us to be proactive immediately in the new year rather than reactive,” says NPA's Dan Fabricant.
Kemin’s ZeaOne Zeaxanthin Gets FDA GRAS
According to Kemin, ZeaOne is the first dietary (3R,3’R) zeaxanthin ingredient derived from marigold flowers with an FDA-acknowledged GRAS notification.
FDA Approves Qualified Health Claim for Resistant Starch, Type 2 Diabetes
Foods and beverages, including bakery, nutrition bar, and cereal and pasta products, can now use the claim.
Don’t Call Plant-Based Milks “Milk,” Congressional Leaders Tell FDA
In a letter to FDA last week, 32 members of Congress asked the agency to find some other name for non-dairy milks.
Does DEA’s Hemp CBD Announcement Actually Change Anything?
Eric Steenstra, executive director of the Hemp Industries Association, says the news that the DEA is creating a new drug code for marijuana extracts has “been blown completely out of proportion.”
Hemp CBD Is a Schedule I Drug, DEA Says
The DEA clarified last week that hemp CBD does indeed fall into Schedule I drug classification of the Controlled Substances Act.
OmniActive’s Capsimax, OmniLean Now Self-Affirmed GRAS
OmniActive’s capsicum and Salacia extracts have both received self-affirmed Generally Recognized as Safe status by an expert panel.
NDI Guidance Comments Get Specific on Chemical Alteration
Many of the public comments sent to FDA this week include specific examples of processes that may or may not result in chemical alteration.
Synthetic Botanicals Should Be Dietary Ingredients, Industry Leaders Tell FDA
In comments responding to FDA’s revised NDI draft guidance, industry trade associations challenge the agency’s stance on nature-identical botanical ingredients.
Top Critiques of FDA’s NDI Draft Guidance in Industry Comments
The comment period closed yesterday for the public to submit comments on FDA’s revised NDI draft guidance. Here are some of the biggest objections from the supplement industry.
GNC’s Department of Justice Deal Is a “Fair Deal,” One Expert Says
GNC was in the hot seat with justice officials after it sold products by USPLabs, a supplement manufacturer indicted in a federal sweep last year for illegally selling misbranded products as dietary supplements.
FDA Makes Public Adverse Event Reports for Foods, Supplements, and Cosmetics
The move is meant to improve transparency, but it may also increase the potential for public misinterpretation of adverse event data.
Nutritional Outlook's 2016 Best of the Industry, Industry Leader: Council for Responsible Nutrition
The trade association is stepping up with a new tool to reset the conversation on industry transparency.
Nutritional Outlook's 2016 Best of the Industry, Retail Brand/Product: KIND
The snacks brand led the way on several key regulatory fronts this year, including successfully petitioning FDA to reevaluate its definition of the term "healthy."
CRN Outlines Priorities for 115th Congress
With more than 60 freshmen members of Congress on the way to Capitol Hill following the 2016 elections, CRN plots its legislative priorities for the 115th Congress.
Is Kratom a Public Health Threat or a Promising Herb in Need of More Research?
Industry leaders offer mixed responses to the DEA’s proposal to reschedule kratom into schedule 1 of the Controlled Substances Act.
Acacia Gum Granted EU Health Claim for Glycemic Reduction
Non-digestible carbohydrates like Nexira’s Fibregum acacia gum have been granted a new health claim from EFSA that says they induce a lower blood-glucose rise than sugars.
AlgaeHealth Submits NDI for “Industry's First” 24-mg Astaxanthin Dose
The New Dietary Ingredient notification for Algae Health Sciences’ AstaZine natural astaxanthin is the first in the industry to exceed a dosage of 12 mg per day, the firm says.
Industry Leaders Slam FDA’s Take on Vinpocetine
FDA has indicated it may reject vinpocetine’s status as a dietary ingredient, but leading industry trade associations argue the agency is reversing past positions in an “unprecedented” move.
BodyHealth’s PerfectAmino Cleared for Professional Athletes
LGC Science has tested and cleared PerfectAmino for the wide range of substances banned by the World Anti-Doping Agency.
CRN Offers First Glimpse of Supplement Online Wellness Library (OWL)
Beta testing of the dietary supplement finished product registry has now entered its second phase, with CRN planning to make the site live in 2017.
FDA’s “No Synthetics” NDI Provision Is a Selling Point for Natural-Botanical Firms
At SupplySide West, natural-botanical suppliers underlined the fact that FDA’s NDI draft guidance does not consider synthetic botanical ingredients to be dietary ingredients.
CurcuWin Curcumin Obtains Self-Affirmed GRAS
OmniActive says its curcumin ingredient has received a self-affirmed Generally Recognized As Safe notification from an expert panel.